PROGNOSTIC FACTORS IN NODULAR TRANSITIONAL-CELL BLADDER-TUMORS

被引:5
|
作者
LIPPONEN, PK
ESKELINEN, MJ
JAUHIAINEN, K
HARJU, E
TERHO, R
HAAPASALO, H
机构
[1] UNIV KUOPIO,DEPT SURG,KUOPIO,FINLAND
[2] MIKKELI CENT HOSP,DEPT SURG,MIKKELI,FINLAND
[3] JYVASKYLA CENT HOSP,DEPT SURG,JYVASKYLA,FINLAND
[4] UNIV TAMPERE,DEPT PATHOL,TAMPERE,FINLAND
来源
关键词
TRANSITIONAL CELL; BLADDER TUMOR; NUCLEAR IMAGE ANALYSIS; MITOTIC INDEX; WHO GRADE; CLINICAL STAGE; SURVIVAL;
D O I
10.3109/00365599309181250
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A cohort of 106 nodular transitional cell bladder cancers (TCC) were followed up for a mean of 9 years. Clinical stage, WHO grade, six morphometric nuclear factors and volume corrected mitotic index (M/V index) were correlated to progression and survival during the follow-up period. Nuclear factors were related to WHO grade with a borderline significance (p=0.01-0.3) whereas the M/V index showed a highly significant relation to WHO grade. Neither nuclear factors nor the M/V index were related significantly to T-, N- or M-categories at the time of diagnosis. Progression in N- and M-categories was related independently to WHO grade whereas progression in T-category could not be predicted significantly by none of the variables included in this analysis. Survival was predicted by T-category (p=0.0028), N-category (p=0.0001), M-category (p=0.0057) and M/V index (p=0.010). In T1-T2N0M0 tumours survival was predicted by the Dmax (p=0.015) and by the M/V index (p=0.039). In multivariate survival analysis T-category (p<0.001) had independent prognostic value. In T1-T2N0M0 tumours only the M/V index predicted survival independently (p=0.007). The results show that only the proliferation rate in addition to T-category have prognostic significance in nodular TCC.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy in transitional-cell carcinoma of the bladder
    McLaren, DB
    CLINICAL ONCOLOGY, 2005, 17 (07) : 503 - 507
  • [22] METACHRONOUS TRANSITIONAL-CELL CARCINOMA OF THE URACHUS AND BLADDER
    SATAKE, I
    NAKAGOMI, K
    TARI, K
    KISHI, K
    BRITISH JOURNAL OF UROLOGY, 1995, 75 (02): : 244 - 244
  • [23] ATYPICAL METASTASIS OF TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
    SCHLICK, RW
    BOKEMEYER, C
    ALLHOFF, EP
    DJAMILIAN, H
    SEIDL, E
    KUCZYK, M
    AKTUELLE UROLOGIE, 1994, 25 (06) : 361 - 363
  • [24] CYTOGENETIC ANALYSIS IN TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
    SCHAPERS, RFM
    SMEETS, AWGB
    PAUWELS, RPE
    VANDENBRANDT, PA
    BOSMAN, FT
    BRITISH JOURNAL OF UROLOGY, 1993, 72 (06): : 887 - 892
  • [25] QUANTITATIVE HISTOPATHOLOGY IN THE PROGNOSTIC EVALUATION OF PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER
    SASAKI, M
    SORENSEN, FB
    FUKUZAWA, S
    YAMABE, H
    OLSEN, S
    YOSHIDA, O
    CANCER, 1993, 72 (08) : 2470 - 2483
  • [26] NEOADJUVANT CHEMOTHERAPY (CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE) IN THE TREATMENT OF INVASIVE TRANSITIONAL CELL BLADDER-TUMORS
    TRIFARD, F
    CHRETIEN, Y
    VALLANTIN, X
    COLLET, C
    LACHAND, AT
    DUFOUR, B
    ANNALES D UROLOGIE, 1988, 22 (03) : 216 - 219
  • [27] PROGNOSTIC FACTORS OF UPPER URINARY-TRACT TRANSITIONAL-CELL CARCINOMA (TCC)
    STEINBACH, F
    STOCKLE, M
    SCHOMER, R
    STEIN, R
    STORKEL, S
    HOMMEL, G
    HOHENFELLNER, R
    AKTUELLE UROLOGIE, 1995, 26 (01) : 52 - 58
  • [28] MENINGEAL CARCINOMATOSIS FROM TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
    ENG, C
    CUNNINGHAM, D
    QUADE, BJ
    SCHWAMM, L
    KANTOFF, PW
    SKARIN, AT
    CANCER, 1993, 72 (02) : 553 - 557
  • [29] TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER IN A CAT
    KOHNO, T
    MATSUDA, H
    FUKATA, T
    MODERN VETERINARY PRACTICE, 1987, 68 (05): : 286 - 287
  • [30] CLITORAL METASTASIS SECONDARY TO TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
    THOMAS, JA
    MATANHELIA, SS
    GRIFFITHS, D
    MATTHEWS, PN
    BRITISH JOURNAL OF UROLOGY, 1994, 74 (04): : 524 - 525